[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: COVOVAX [SARS-CoV-2 recombinant spike protein nanoparticle vaccine(SARS-CoV-2 rS) with Matrix-M1\u00e2?\u00a2 adjuvant]: Single dose of 0.5 mL contains 5 \u00ce\u00bcg antigen and 50 \u00ce\u00bcg Matrix-M1 adjuvant.Dose: 0.5 mLFrequency: Single doseRoute of administration: IntramuscularControl Intervention1: SII Td-Vac\u00c2\u00ae [Diphtheria and Tetanus Vaccine (Adsorbed) for Adults and Adolescents I.P.]: Single dose of 0.5 mL contains Diphtheria Toxoid \u00e2?\u00a45 Lf ( \u00e2?\u00a52 IU); Tetanus Toxoid \u00e2?\u00a55 Lf ( \u00e2?\u00a540 IU); Adsorbed on Aluminium Phosphate; Al+++ 1.25 mg; Preservative: 0.005% ThiomersalControl Intervention2: COVISHIELD: COVISHIELD (ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant))One dose (0.5 ml) contains:ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant) 5 \u00c3? 1010virus particles (vp)Recombinant; replication-deficient chimpanzee adenovirus vector encodingthe SARS-CoV-2 Spike (S) glycoprotein. Produced in genetically modifiedhuman embryonic kidney (HEK) 293 cells.Manufacturer- Serum Institute of India Pvt. Ltd.Dose: 0.5 mL Frequency: Single dose Route of administration: IntramuscularControl Intervention3: COVAXIN: COVAXIN (Whole Virion Inactivated Coronavirus (SARS-CoV-2) Vaccine) is a white to off white; opalescent suspension free fromextraneous particles containing 6 \u00ce\u00bcg of Whole Virion; Inactivated(SARS-CoV-2) Antigen (strain NIV-2020-770).Manufacturer- Bharat Biotech International LimitedDose: 0.5 mL Frequency: Single dose Route of administration: Intramuscular", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: COVOVAX [SARS-CoV-2 recombinant spike protein nanoparticle vaccine(SARS-CoV-2 rS) with Matrix-M1\u00e2?\u00a2 adjuvant]: Single dose of 0.5 mL contains 5 \u00ce\u00bcg antigen and 50 \u00ce\u00bcg Matrix-M1 adjuvant.Dose: 0.5 mLFrequency: Single doseRoute of administration: IntramuscularControl Intervention1: SII Td-Vac\u00c2\u00ae [Diphtheria and Tetanus Vaccine (Adsorbed) for Adults and Adolescents I.P.]: Single dose of 0.5 mL contains Diphtheria Toxoid \u00e2?\u00a45 Lf ( \u00e2?\u00a52 IU); Tetanus Toxoid \u00e2?\u00a55 Lf ( \u00e2?\u00a540 IU); Adsorbed on Aluminium Phosphate; Al+++ 1.25 mg; Preservative: 0.005% ThiomersalControl", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention2: COVISHIELD: COVISHIELD (ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant))One dose (0.5 ml) contains:ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant) 5 \u00c3? 1010virus particles (vp)Recombinant; replication-deficient chimpanzee adenovirus vector encodingthe SARS-CoV-2 Spike (S) glycoprotein. Produced in genetically modifiedhuman embryonic kidney (HEK) 293 cells.Manufacturer- Serum Institute of India Pvt. Ltd.Dose: 0.5 mL Frequency: Single dose Route of administration: IntramuscularControl", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: SII Td-Vac\u00c2\u00ae [Diphtheria and Tetanus Vaccine (Adsorbed) for Adults and Adolescents I.P.]: Single dose of 0.5 mL contains Diphtheria Toxoid \u00e2?\u00a45 Lf ( \u00e2?\u00a52 IU); Tetanus Toxoid \u00e2?\u00a55 Lf ( \u00e2?\u00a540 IU); Adsorbed on Aluminium Phosphate; Al+++ 1.25 mg; Preservative: 0.005% ThiomersalControl Intervention2: COVISHIELD: COVISHIELD (ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant))One dose (0.5 ml) contains:ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant) 5 \u00c3? 1010virus particles (vp)Recombinant; replication-deficient chimpanzee adenovirus vector encodingthe SARS-CoV-2 Spike (S) glycoprotein. Produced in genetically modifiedhuman embryonic kidney (HEK) 293 cells.Manufacturer- Serum Institute of India Pvt. Ltd.Dose: 0.5 mL Frequency: Single dose Route of administration: IntramuscularControl Intervention3: COVAXIN: COVAXIN (Whole Virion Inactivated Coronavirus (SARS-CoV-2) Vaccine) is a white to off white; opalescent suspension free fromextraneous particles containing 6 \u00ce\u00bcg of Whole Virion; Inactivated(SARS-CoV-2) Antigen (strain NIV-2020-770).Manufacturer- Bharat Biotech International LimitedDose: 0.5 mL Frequency: Single dose Route of administration: Intramuscular", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1387, "treatment_name": "Covaxin", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 161, "treatment_name": "Chadox1 ncov-19", "treatment_type": "Non replicating viral vector", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 1158, "treatment_name": "Sars-cov-2 rs/matrix-m1 adjuvant", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}]